Market Closed -
Hong Kong S.E.
09:08:35 22/05/2024 BST
|
5-day change
|
1st Jan Change
|
6.28
HKD
|
+1.13%
|
|
+3.12%
|
-12.53%
|
Fiscal Period: March |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
6,819
|
7,388
|
2,585
|
-
|
-
|
Enterprise Value (EV)
1 |
6,446
|
7,722
|
2,784
|
2,697
|
2,607
|
P/E ratio
|
-1.35
x
|
-33.4
x
|
437
x
|
31.7
x
|
20.9
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
4.2
x
|
5.01
x
|
1.44
x
|
1.24
x
|
1.05
x
|
EV / Revenue
|
3.97
x
|
5.24
x
|
1.55
x
|
1.29
x
|
1.06
x
|
EV / EBITDA
|
33.2
x
|
29.4
x
|
8.14
x
|
5.79
x
|
4.99
x
|
EV / FCF
|
-
|
-
|
7.1
x
|
11.1
x
|
9.21
x
|
FCF Yield
|
-
|
-
|
14.1%
|
8.97%
|
10.9%
|
Price to Book
|
4.36
x
|
4.57
x
|
2.02
x
|
1.9
x
|
1.7
x
|
Nbr of stocks (in thousands)
|
581,592
|
581,592
|
449,104
|
-
|
-
|
Reference price
2 |
11.72
|
12.70
|
5.757
|
5.757
|
5.757
|
Announcement Date
|
27/06/22
|
27/06/23
|
-
|
-
|
-
|
Fiscal Period: March |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
1,624
|
1,474
|
1,791
|
2,091
|
2,459
|
EBITDA
1 |
-
|
194.2
|
263
|
342.1
|
465.8
|
522.5
|
EBIT
1 |
-
|
-28.57
|
-190.3
|
69.2
|
178.5
|
247.7
|
Operating Margin
|
-
|
-1.76%
|
-12.91%
|
3.86%
|
8.54%
|
10.07%
|
Earnings before Tax (EBT)
1 |
-
|
-709.9
|
-217.9
|
26.81
|
157.3
|
222.3
|
Net income
1 |
-599.4
|
-701
|
-219.9
|
20.75
|
110.1
|
176.1
|
Net margin
|
-
|
-43.18%
|
-14.92%
|
1.16%
|
5.27%
|
7.16%
|
EPS
2 |
-0.3286
|
-8.700
|
-0.3800
|
0.0132
|
0.1817
|
0.2750
|
Free Cash Flow
1 |
-
|
-
|
-
|
392
|
242
|
283
|
FCF margin
|
-
|
-
|
-
|
21.88%
|
11.57%
|
11.51%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
114.59%
|
51.96%
|
54.17%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
1,889.04%
|
219.75%
|
160.72%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
24/01/22
|
27/06/22
|
27/06/23
|
-
|
-
|
-
|
Fiscal Period: March |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
334
|
199
|
112
|
21.9
|
Net Cash position
1 |
-
|
373
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
1.269
x
|
0.5804
x
|
0.2398
x
|
0.042
x
|
Free Cash Flow
1 |
-
|
-
|
-
|
392
|
242
|
283
|
ROE (net income / shareholders' equity)
|
-
|
-15%
|
-1.84%
|
2.33%
|
6.49%
|
8.9%
|
ROA (Net income/ Total Assets)
|
-
|
2.46%
|
-
|
0.3%
|
2.9%
|
-
|
Assets
1 |
-
|
-28,452
|
-
|
6,917
|
3,797
|
-
|
Book Value Per Share
2 |
-
|
2.690
|
2.780
|
2.850
|
3.020
|
3.390
|
Cash Flow per Share
2 |
-
|
2.780
|
-
|
1.370
|
0.7800
|
-
|
Capex
1 |
-
|
116
|
108
|
362
|
281
|
302
|
Capex / Sales
|
-
|
7.12%
|
7.34%
|
20.2%
|
13.43%
|
12.26%
|
Announcement Date
|
24/01/22
|
27/06/22
|
27/06/23
|
-
|
-
|
-
|
Last Close Price
5.757
CNY Average target price
8.663
CNY Spread / Average Target +50.49% Consensus |
1st Jan change
|
Capi.
|
---|
| -12.53% | 357M | | +18.63% | 84.11B | | -27.41% | 71.96B | | +1.97% | 27.25B | | -9.66% | 17.31B | | -1.71% | 16.83B | | +3.96% | 15.92B | | +7.75% | 13.68B | | +72.83% | 13.29B | | +72.50% | 12.73B |
Other Healthcare Facilities & Services
|